Say Goodbye to Tanks and Pumps: WillScot Mobile Mini Holdings Makes a Big Move with Kinderhook Industries!

Welcome to the World of Portable Storage Solutions! WillScot Mobile Mini Holdings Divests Tank and Pump Segment Phoenix, Aug. 22, 2022 (GLOBE NEWSWIRE) Hey there, fellow storage enthusiasts! Big news in the world of portable storage solutions – WillScot Mobile Mini Holdings Corp. has announced an agreement to divest its Tank and Pump segment to…

Read More

Johnson Fistel, Globally Recognized Law Firm, Urges Shareholders to Submit Losses in Lottery.com Class Action Complaint

Lottery.com Class Action Complaint Filed: Johnson Fistel, Globally-Recognized Law Firm Encourages Shareholders to Submit Their Lo… Overview On August 20, 2022, shareholder rights law firm Johnson Fistel, LLP announced that a class action lawsuit has commenced on behalf of investors of Lottery.com Inc. (“Lottery.com” or “the Company”) (NASDAQ: LTRY). The class action is on behalf…

Read More

Attention Solana Investors: Protect Your Interests Before the Securities Class Action Deadline, Advises Rosen Global Investor Counsel

Important Deadline for Solana Investors ROSEN Law Firm Reminds Investors of Class Action Lawsuit Against Solana Labs New York, Aug. 20, 2022 (GLOBE NEWSWIRE) – ROSEN Law Firm, a global investor rights law firm, is reminding purchasers of SOL tokens (“SOL securities”) between March 24, 2020 and the present, inclusive, of the upcoming September 6,…

Read More

Breaking News: P3 Health Partners Receives Nasdaq Notice for Late Filing of Periodic Report

P3 Health Partners Announces Receipt of Nasdaq Notice Regarding Late Filing of Periodic Report Introduction HENDERSON, Nev., Aug. 19, 2022 (GLOBE NEWSWIRE) — P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that on August 17, 2022 it received a notice (the “Notice”) from…

Read More

Emerald Health Therapeutics Shareholders Approve Plan of Arrangement with Skye Bioscience: A Promising Partnership in the World of Biotechnology

Skye Bioscience Reports that Emerald Health Therapeutics Shareholders Voted in Favor of Plan of Arrangement San Diego, California, Aug. 19, 2022 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, reports that the shareholders of Emerald Health Therapeutics, Inc. (“Emerald”…

Read More